LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will present at the LD 500 investor conference on Wednesday, September 2 at 11:40 AM Eastern Time. Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will be presenting to a live virtual audience and available for investor meetings throughout the day.
Investors interested in attending the presentation can register online at https://ld500.ldmicro.com/ to join the group presentation session. A free profile for APEN is available at http://www.ldmicro.com/profile/APEN. Institutional and other qualified investors may request one-on-one meetings via LD Micro if they have an existing relationship, or by contacting APEN's investor relations, Matt Kreps of Darrow Associates, at [email protected].
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.
About LD Micro
Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.
What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.
The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.
Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
SOURCE: Apollo Endosurgery, Inc. via LD Micro